Skip to main content
SpringerLink
Log in

The Management of Urinary Tract Infections

  • Chapter
Therapy of Renal Diseases and Related Disorders

Abstract

The management of infections of the urinary tract provides a continuing challenge to the physician for a variety of reasons. They are common-an estimated 10–20% of women will experience one. They may be painfully symptomatic or entirely silent. They tend to recur, in some with near incapacitating frequency. Approaches to therapy have been shifting, with emphasis on shorter duration of treatment on one end of the spectrum and longer on the other. Finally, perspective on their long- term risks is being clarified, with reassurance for most, but with definition of populations in whom their consequences may be critical.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Fairley KF: The routine determination of the site of infection in the investigation of patients with urinary tract infection. In: Kincaid-Smith P, Fairley KF (eds) Renal Infection and Renal Scarring. Mercedes, Melboume, 1970, pp 107–116.

    Google Scholar 

  2. Thomas VL, Forland M: The significance of antibody- coated bacteria in urinary tract infections. Kidney Int 21: 1–7, 1982.

    Article  PubMed  CAS  Google Scholar 

  3. Carvajal HF, Pasey RB, Berger M, et al: Urinary lactic dehydrogenase isoenzyme 5 in the differential diagnosis of kidney and bladder infection. Kidney Int 8: 176–184, 1976.

    Article  Google Scholar 

  4. Schwartz H, Schirmer HKA, Post B, et al: Correlation of Escherichia coli occurring simultaneously in the urine and stool of patients with clinically significant bacteriuria: Serotyping with group-specific O antisera. J Urol 101:379– 382, 1969.

    Google Scholar 

  5. Glynn AA, Bmmfitt W, Howard CJ: K antigens of Escherichia coli and renal involvement in urinary tract infections. Lancet 1: 514–516, 1971.

    Article  PubMed  CAS  Google Scholar 

  6. Ofek I, Beachey EH: Bacterial adherence. Adv Intem Med 25: 503–532, 1980.

    CAS  Google Scholar 

  7. Musher DM, Griffith DP, Yawn D, et al: Role of urease in pyelonephritis resulting from urinary tract infection with Proteus. J Infect Dis 131: 177–181, 1975.

    Article  PubMed  CAS  Google Scholar 

  8. Guze LB, Kalmanson GM: Persistence of bacteria in ‘protoplast’ form after apparent cure of pyelonephritis in rats. Science 143: 1340–1341, 1964.

    Article  PubMed  CAS  Google Scholar 

  9. Stamey TA, Sexton CC: The role of vaginal colonization with enterobacteriaceae in recurrent urinary infections. J Urol 113: 214–217, 1975.

    PubMed  CAS  Google Scholar 

  10. Cattell WR, McSherry MA, Northeast A, et al: Periurethral enterobacterial carriage in pathogenesis of recurrent urinary infection. Br Med J 4: 136–139, 1974.

    Article  PubMed  CAS  Google Scholar 

  11. Stamey TA, Timothy MM: Studies of introital colonization in women with recurrent urinary tract infections. I. Tole of vaginal pH. J Urol 114: 261–263, 1975.

    PubMed  CAS  Google Scholar 

  12. Fowler JE Jr, Stamey TA: Studies of introital colonization in women with recurrent urinary infections. VII. The role of bacterial adherence. J Urol 117: 472–476, 1977.

    PubMed  Google Scholar 

  13. Schaeffer AJ, Jones JM, Dunn JK: Association of in vitro Eschericia coli adherence to vaginal and buccal epithelial cells with susceptibility of women to recurrent urinary tract infections. N Engl J Med 304: 1062–1066, 1981.

    Article  PubMed  CAS  Google Scholar 

  14. Stamey TA, Wehner N, Mihara G, et al: The immunologic basis of recurrent bacteriuria: Role of cervicovaginal antibody in enterobacterial colonization of the introital mucosa. Medicine 57: 47–56, 1978.

    Article  PubMed  CAS  Google Scholar 

  15. Kurdydyk LM, Kelly K, Harding GKM, et al: Role of cervicovaginal antibody in the pathogenesis of recurrent urinary tract infection in women. Infect Immunol 29:76– 82, 1980.

    Google Scholar 

  16. Bran JL, Levison ME, Kaye D: Entrance of bacteria into the female urinary bladder. N Engl J Med 286: 626–629, 1972.

    Article  PubMed  CAS  Google Scholar 

  17. Buckley RM Jr, McGuckin M, MacGregor RR: Urine bacterial counts after sexual intercourse. N Engl J Med 298: 321–324, 1978.

    Article  PubMed  Google Scholar 

  18. Cox CE, Hinman F: Experiments with induced bacteriuria, vesical emptying and bacterial growth on the mechanism of bladder defense to infection. J Urol 86: 739–748, 1961.

    PubMed  CAS  Google Scholar 

  19. Vivaldi E, Cotran R, Zangwill DP, et al: Ascending infection as a mechanism in pathogenesis of experimental nonobstructive pyelonephritis. Proc Soc Exp Biol Med 102: 242–244, 1959.

    Google Scholar 

  20. Chemew I, Braude AI: Depression of phagocytosis by solutes in concentrations found in the kidney and urine. J Clin Invest 41: 1945–1953, 1962.

    Article  Google Scholar 

  21. Beeson PB, Rowley D: The anti-complementary effect of kidney tissue. J Exp Med 110: 685–697, 1959.

    Article  PubMed  CAS  Google Scholar 

  22. Fair WR, Wehner N: The prostatic antibacterial factor: identity and significance, in: Marberger H, Haschek H, Schirmer HKA, et al (eds) Prostatic Disease. Alan R Liss, New York, 1976, pp 383–403.

    Google Scholar 

  23. Kass EH: Asymptomatic infections of the urinary tract. Trans Assoc Am Phys 69: 56–63, 1956.

    PubMed  CAS  Google Scholar 

  24. Kass EH: Bacteriuria and the diagnosis of infections of the urinary tract; with observations on the use of methionine as a urinary antiseptic. Arch Intern Med 100: 709–714, 1957.

    CAS  Google Scholar 

  25. Simon HB, Weinstein AJ, Pasternak MS, et al: Genitourinary tuberculosis: Clinical features in a general hospital population. Am J Med 63: 410–420, 1977.

    Article  PubMed  CAS  Google Scholar 

  26. Stamm WE, Wagner KF, Amsel R, et al: Causes of the acute urethral syndrome in women. N Engl J Med 303: 409–415, 1980.

    Article  PubMed  CAS  Google Scholar 

  27. Lindner LE, Jones RN, Haber MH: A specific urinary cast in acute pyelonephritis. Am J Clin Pathol 73:809– 811, 1980.

    Google Scholar 

  28. Kunin CM: The quantitative significance of bacteria visualized in the unstained urinary sediment. N Engl J Med 265: 589, 1961.

    Article  PubMed  CAS  Google Scholar 

  29. Cohen S, Kass EH: A simple method for quantitative urine culture. N Engl J Med 277: 176–180, 1967.

    Article  PubMed  CAS  Google Scholar 

  30. Dodge WF, West EF, Fras PA, et al: Detection of bacteriuria in children. J Ped 74: 107–110, 1969.

    Article  CAS  Google Scholar 

  31. Bennett WM, Muther RS, Parker RA, et al: Drug therapy in renal failure: dosing guidelines for adults. Part 1. Antimicrobial agents, analgesics. Ann Intern Med 93: 62–89, 1980.

    PubMed  CAS  Google Scholar 

  32. Levison SP, Kaye D: Response of enterococcal pyelonephritis to furosemide-induced diuresis alone and in combination with ampicillin. J Infect Dis 127: 626–631, 1973.

    Article  CAS  Google Scholar 

  33. Freedman LR: Experimental pyelonephritis. XIII. On the ability of water diuresis to induce susceptibility to E. coli bacteriuria in the normal rat. Yale J Biol Med 39:255– 266, 1967.

    Google Scholar 

  34. Ronald AR, Cutler RE, Turck M: Effect of bacteriuria on renal concentrating mechanisms. Ann Intern Med 70: 723–733, 1969.

    PubMed  CAS  Google Scholar 

  35. Clark H, Ronald AR, Cutler RE, et al: The correlation between the site of infection and maximal concentrating ability in bacteriuria. J Infect Dis 120: 47–53, 1969.

    Article  PubMed  CAS  Google Scholar 

  36. Lathem W: Hyperchloremic acidosis in chronic pyelonephritis. N Engl J Med 258: 1031–1036, 1958.

    Article  PubMed  CAS  Google Scholar 

  37. Schambelan M, Sebastian A, Hulter HN: Mineralocorticoid excess and deficiency syndromes. Contemporary Issues in Nephrology 2: 232–268, 1978.

    CAS  Google Scholar 

  38. Fair WR, McClennan BL, Jost RG: Are excretory urograms necessary in evaluating women with urinary tract infection? J Urol 121: 313–315, 1979.

    PubMed  CAS  Google Scholar 

  39. Fowler JE Jr, Pulaski ET: Excretoty urography, cystography, and cystoscopy in the evaluation of women with urinary-tract infection: a prospective study. N Engl J Med 304: 462–465, 1981.

    Article  PubMed  Google Scholar 

  40. Thorley JD, Jones SR, Sanford JP: Perinephric abscess. Medicine 53: 441–451, 1974.

    Article  PubMed  CAS  Google Scholar 

  41. Cardiff-Oxford Bacteriuria Study Group: The sequelae of covert bacteriuria in schoolgirls. Lancet 1: 889–893, 1978.

    Google Scholar 

  42. Sabath LD, Gerstein DA, Loder PB, et al: Excretion of erythromycin and its enhanced activity in urine against gram-negative bacilli with alkalinization. J Lab Clin Med 72: 916–923, 1968.

    PubMed  CAS  Google Scholar 

  43. Brumfitt W, Percival A: Adjustment of urine pH in the chemotherapy of urinary tract infection. Lancet 1:186– 190, 1962.

    Google Scholar 

  44. Komaroff AL, Pass TM, McCue JD, et al: Management strategies for urinary and vaginal infections. Arch Intern Med 138: 1069–1073, 1978.

    Article  PubMed  CAS  Google Scholar 

  45. Fang LST, Tolkoff-Rubin NE, Rubin RH: Efficacy of single-dose and conventional amoxicillin therapy in urinary- tract infection localized by the antibody-coated bacteria technic. N Engl J Med 298: 413–416, 1978.

    Article  PubMed  CAS  Google Scholar 

  46. Rubin RH, Fang LST, Jones SR, et al: Single dose amoxicillin therapy for urinary tract infection: multicenter trial using antibody-coated bacteria localization technique. JAMA 244: 561–564, 1980.

    Article  PubMed  CAS  Google Scholar 

  47. Bailey RR, Abbott GD: Treatment of urinary tract infection with a single dose of trimethoprim-sulfamethoxazole. Can Med Assoc J 118: 551–552, 1978.

    PubMed  CAS  Google Scholar 

  48. Ludwig P, Buckwold F, Harding G, et al: Single-dose therapy of acute cystitis in adult females: Prospective randomized comparison of four regimes. In: Neison JD, Grassi C (eds) Current Chemotherapy and Infectious Disease. Proceedings of the 11th International Congress on Chemotherapy, 19th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, D.C., American Society of Microbiology, 1980, pp 1297–1298.

    Google Scholar 

  49. Ronald AR, Boutros P, Mourtada H: Bacteriuria localization and response to single-dose therapy in women. JAMA 235: 1854–1856, 1976.

    Article  PubMed  CAS  Google Scholar 

  50. Stamm WE: Single-dose treatment of cystitis. JAMA 244: 591–592, 1980.

    Article  PubMed  CAS  Google Scholar 

  51. Turck M, Ronald AR, Petersdorf RG: Relapse and reinfection in chronic bacteriuria. II. The correlation between site of infection and pattern of recurrence in chronic bacteriuria. N Engl J Med 278: 422–427, 1968.

    Article  PubMed  CAS  Google Scholar 

  52. Cattell WR, Charlton CAC, McSherry A, et al: The localization of urinary tract infection and its relationship to 73. relapse, reinfection and treatment. In: Brumfitt W, Asscher AW (eds) Urinary Tract Infection. Oxford University Press, London, 1973, pp 206–214.

    Google Scholar 

  53. McGeachie J: Recurrent infection of the urinary tract: reinfection or recrudescence? Br Med J 1: 952–954, 75. 1966.

    Google Scholar 

  54. Turck M, Browder AA, Lindemeyer RJ, et al: Failure of prolonged treatment of chronic urinary tract infections with antibiotics. N Engl J Med 267: 999–1005, 1962.

    Article  PubMed  CAS  Google Scholar 

  55. Kincaid-Smith P, Fairiey KF: Controlled trial comparing effect of two and six weeks’ treatment in recurrent urinary tract infection. Br Med J 2: 145–146, 1969.

    Article  PubMed  CAS  Google Scholar 

  56. Harding GKM, Ronald AR: A controlled study of antimicrobial prophylaxis of recurrent urinary infection in women. N Engl J Med 291: 597–601, 1974.

    Article  PubMed  CAS  Google Scholar 

  57. Stamey TA, Condy M, Mihara G: Prophylactic efficacy of nitrofurantoin macrocrystals and trimethoprim-sulfamethoxazole in urinary infection. N Engl J Med 296: 780–783, 1977.

    Article  PubMed  CAS  Google Scholar 

  58. Harding GKM, Buckwold FJ, Marrie TJ, et al: Prophylaxis of recurrent urinary tract infection in female patients: efficacy of low-dose thrice-weekly therapy with trimethoprim-sulfamethoxazole. JAMA 242: 1975–1977, 1979.

    Article  PubMed  CAS  Google Scholar 

  59. Vosti KL: Recurrent urinary tract infections: prevention by prophylactic antibiotics after sexual intercourse. JAMA 231: 934–940, 1975.

    Article  PubMed  CAS  Google Scholar 

  60. Brooks D, Maudar A: Pathogenesis of the urethral syndrome in women and its diagnosis in general practice. Lancet 2: 893–898, 1972.

    Article  PubMed  CAS  Google Scholar 

  61. Chariton CAC, Cattell WR, Canti G, et al: The non-urethral syndrome. Brumfitt W, Asscher AW (eds) Urinary Tract Infection. Oxford University Press, London, 1973, pp 173–177.

    Google Scholar 

  62. Cattell WR, Brooks HL, McSherry MA, et al: Approach to the frequency and dysuria syndrome. Kidney Int 85. 8: S138–S143, 1975.

    Google Scholar 

  63. Meares EM: Prostatitis: a review. Urol Clin N Am 2:3– 27, 1975.

    Google Scholar 

  64. Meares EM, Stamey TA: Bactériologie localization patterns in bacterial prostatitis and urethritis. Invest Urol 5: 492–518, 1968.

    PubMed  CAS  Google Scholar 

  65. Stamey TA, Bushby SRM, Bragonje J: The concentration of trimethoprim in prostatic fluid: non-ionic diffusion or active transport? J Infect Dis 128: S686–S690, 1973.

    Article  CAS  Google Scholar 

  66. Smith JW, Jones SR, Reed WP, et al: Recurrent urinary tract infections in men: characteristics and response to therapy. Ann Intern Med 91: 544–548, 1979.

    PubMed  CAS  Google Scholar 

  67. Gleckman R, Crowley M, Natsios GA: Therapy of recurrent invasive urinary-tract infections of men. N Engl J Med 301: 878–880, 1979.

    Article  PubMed  CAS  Google Scholar 

  68. Stamm WE: Guidelines for prevention of catheter-associated urinary tract infections. Ann Intern Med 82: 386–390, 1975.

    PubMed  CAS  Google Scholar 

  69. Martin CM, Bookrajian EN: Bacteriuria prevention after indwelling urinary catheterization: a controlled study. Arch Intern Med 110: 703–711, 1962.

    Google Scholar 

  70. Warren JW, Piatt R, Thomas RJ, et al: Antibiotic irrigation and catheter-associated urinary-tract infection. N Engl J Med 299: 570–573, 1978.

    Article  PubMed  CAS  Google Scholar 

  71. Kunin CM: Tendency of vesicoureteric reflux to disappear coincident with specific antimicrobial therapy. In: Kincaid-Smith P, Fairiey KF (eds Renal Infection and Renal Scarring. Mercedes, Melbourne, 1970, pp 287–292.

    Google Scholar 

  72. Hodson CJ, Maling TMJ, McManamon PJ, et al: The pathogenesis of reflux nephropathy (chronic atrophic pyelonephritis). Br J Radiol (Suppl) 13: 1–26, 1975.

    Google Scholar 

  73. Torres VE, Velosa JA, Holley KE, et al: The progression of vesicoureteral reflux nephropathy. Ann Intern Med 92: 776–784, 1980.

    PubMed  CAS  Google Scholar 

  74. Smellie JM, Normand ICS: Bacteriuria, reflux and renal scarring. Arch Dis Child 50: 581–585, 1975.

    Article  PubMed  CAS  Google Scholar 

  75. Normand C, Smellie J: Vesicoureteric reflux: the case for conservative management. In: Hodson J, Kincaid-Smith P (eds) Reflux Nephropathy. Masson Publishing, New York, 1979, pp 281–286.

    Google Scholar 

  76. Kunin CM: A ten year study of bacteriuria in schoolgiris: final report of bacteriologic, urologie and epidemiologic findings. J Infect Dis 122: 382–393, 1970.

    Article  PubMed  CAS  Google Scholar 

  77. Kunin CM: The natural history of recurrent bacteriuria in schoolgiris. N Engl J Med 282: 1443–1448, 1970.

    Article  PubMed  CAS  Google Scholar 

  78. Manners BTB, Grob PR, Dulake C, et al: The interrelationships of asymptomatic bacteriuria, acute bacterial pyelonephritis and bacterial cystitis in women. In: Brumfitt W, Asscher AW (eds) Urinary Tract Infection. Oxford University Press, London, 1973, pp 186–194.

    Google Scholar 

  79. Kaitz AL: Urinary concentrating ability in prepant women with asymptomatic bacteriuria. J Clin Invest 40: 1331–1338, 1961.

    Article  PubMed  CAS  Google Scholar 

  80. Percival A, Brumfitt W, DeLouvois J: Serum-antibody levels as an indication of clinically inapparent pyelonephritis. Lancet 2: 1027–1033, 1964.

    Article  PubMed  CAS  Google Scholar 

  81. Miall WE, Kass EH, Ling J: Factors influencing arterial pressure in the general population in Jamaica. Br Med J 2: 497–506, 1962.

    Article  PubMed  CAS  Google Scholar 

  82. Kass EH: Horatio at the orifice: the significance of bacteriuria. J Infect Dis 138: 546–557, 1978.

    Article  PubMed  CAS  Google Scholar 

  83. Norden CW, Kass EH: Bacteriuria of pregnancy - A critical appraisal. Annu Rev Med 19: 431–470, 1968.

    Article  PubMed  CAS  Google Scholar 

  84. Condi AP, Brumfitt W, Reeves DS, et al: The effects of bacteriuria in pregnancy on foetal health. In: Brumfitt W, Asscher AW (eds) Urinary Tract Infection. Oxford University Press, London, 1973, pp 108–116.

    Google Scholar 

  85. Williams JD, Reeves DS, Brumfitt W, et al: The effects of bacteriuria in pregnancy on maternal health. In: Brumfitt W, Asscher AW (eds) Urinary tract Infection. Oxford University Press, London, 1973, pp 103–107.

    Google Scholar 

  86. Harris R, Thomas V, Shelokov A: Asymptomatic bacteriuria in pregnancy: antibody-coated bacteria, renal function, and intrauterine growth retardation. Am J Obstet Gynecol 126: 20–25, 1976.

    PubMed  CAS  Google Scholar 

  87. Forland M, Thomas V, Shelokov A: Urinary tract infections in patients with diabetes mellitus: Studies on antibody-coating of bacteria. JAMA 238: 1924–1926, 1977.

    Article  PubMed  CAS  Google Scholar 

  88. McCabe WR: Gram-negative bacteremia. Adv Intern Med 19: 135–158, 1974.

    PubMed  CAS  Google Scholar 

  89. Wolff S: Biological effects of bacterial endotoxins in man. J Infect Dis 128: S259–S264, 1973.

    Article  Google Scholar 

  90. Winslow EJ, Loeb HS, Rahimtoola SH, et al: Hemodynamic studies and results of therapy in 50 patients with bacteremic shock. Am J Med 54: 421–432, 1973.

    Article  PubMed  CAS  Google Scholar 

  91. Schumer W: Steroids in the treatment of clinical septic shock. Ann Surg 184: 333–341, 1976.

    Article  PubMed  CAS  Google Scholar 

  92. Gloor FJ: Changing concepts in pathogenesis and morphology of analgesic nephropathy as seen in Europe. Kidney Int 13: 27–33, 1978.

    Article  PubMed  CAS  Google Scholar 

  93. Murray T, Goldberg M: Chronic interstitial nephritis: etiologic factors. Ann Intern Med 82: 453–459, 1975.

    PubMed  CAS  Google Scholar 

  94. Lindvall N: Radiological changes of renal papillary necrosis. Kidney Int 13: 93–106, 1978.

    Article  PubMed  CAS  Google Scholar 

  95. Chinn RH, Maskell R, Mead JA, et al: Renal stones and urinary infection: a study of antibiotic treatment. Br Med J 2: 1411–1413, 1976.

    Article  PubMed  CAS  Google Scholar 

  96. Nemoy MJ, Stamey TA: Surgical, bacteriological and biochemical management of infection stones. JAMA 215: 1470–1476, 1971.

    Article  PubMed  CAS  Google Scholar 

  97. Kleeman SET, Freedman LR: The finding of chronic pyelonephritis in males and females at autopsy. N Engl J Med 263: 988–992, 1960.

    Article  PubMed  CAS  Google Scholar 

  98. Kimmelstiel P, Kim OJ, Beres JA, et al: Chronic pyelonephritis. Am J Med 30: 589–607, 1961.

    Article  PubMed  CAS  Google Scholar 

  99. Freedman LR: Chronic pyelonephritis at autopsy. Ann Intern Med 66: 697–710, 1967.

    PubMed  CAS  Google Scholar 

  100. Schechter H, Leonard CD, Scribner BH: Chronic pyelonephritis as a cause of renal failure in dialysis candidates. JAMA 216: 514–517, 1971.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Marvin Forland
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The Bernard J. Hanley, Los Angeles, CA, 90033, USA

    Wadi N. Suki M.D. (Professor of Medicine Professor of Physiology and Biophysics Chief) (Professor of Medicine Professor of Physiology and Biophysics Chief)

  2. Division of Nephrology, University of Southern California School of Medicine, Los Angeles, CA, 90033, USA

    Wadi N. Suki M.D. (Professor of Medicine Professor of Physiology and Biophysics Chief) (Professor of Medicine Professor of Physiology and Biophysics Chief)

  3. Renal Section Baylor College of Medicine, The Methodist Hospital, Houston, TX, 77030, USA

    Shaul G. Massry M.D. (Professor of Medicine and Physiology Chief) (Professor of Medicine and Physiology Chief)

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Martinus Nijhoff Publishing, Boston/ The Hague/ Dordrecht/ Lancaster

About this chapter

Cite this chapter

Forland, M. (1984). The Management of Urinary Tract Infections. In: Suki, W.N., Massry, S.G. (eds) Therapy of Renal Diseases and Related Disorders. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-3807-9_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-3807-9_16

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-3809-3

  • Online ISBN: 978-1-4613-3807-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation